Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.70 |
| ▸ | EGFR | P00533 | 5/20 | 0.58 |
| ▸ | ERBB2 | P04626 | 5/20 | 0.58 |
| ▸ | ERBB3 | P21860 | 5/20 | 0.58 |
| ▸ | ERBB4 | Q15303 | 5/20 | 0.58 |
| ▸ | TEK | Q02763 | 4/20 | 0.58 |
| ▸ | NTRK2 | Q16620 | 4/20 | 0.52 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.52 |
| ▸ | NTRK3 | Q16288 | 2/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.47 |
| ▸ | RET | P07949 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 3/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1941712 | 0.93 | PDGFRB (0.64) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1939252 | 0.92 | EGFR (0.65) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1939981 | 0.92 | PDGFRB (0.64) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1941202 | 0.91 | PDGFRB (0.73) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1941531 | 0.91 | PDGFRB (0.66) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1939499 | 0.91 | PDGFRB (0.64) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1940426 | 0.90 | PDGFRB (0.73) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| Ce-245677 SCHEMBL1940683 | 0.89 | PDGFRB (0.61) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| Ce-245677 SCHEMBL29392014 | 0.89 | PDGFRB (0.61) | PDGFRBEGFRERBB2ERBB3ERBB4 | |
| SCHEMBL1941041 | 0.89 | PDGFRB (0.60) | PDGFRBEGFRERBB2ERBB3ERBB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1578751-B1 | PYRROLOPYRIMIDINE DERIVATIVES | PFIZER PROD INC (US) | 2011-06-15 | — | — | EP | claimed |
| US-7271262-B2 | Pyrrolopyrimidine derivatives | PFIZER INC (US) | 2007-09-18 | — | — | US | claimed |
| US-20050037999-A1 | Pyrrolopyrimidine derivatives | PFIZER INC | 2005-02-17 | — | — | US | claimed |
| EP-1578751-B1 | PYRROLOPYRIMIDINE DERIVATIVES | PFIZER PROD INC (US) | 2011-06-15 | — | — | EP | disclosed |
| US-7271262-B2 | Pyrrolopyrimidine derivatives | PFIZER INC (US) | 2007-09-18 | — | — | US | disclosed |
| EP-1578751-A1 | PYRROLOPYRIMIDINE DERIVATIVES | Pfizer Products Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20050037999-A1 | Pyrrolopyrimidine derivatives | PFIZER INC | 2005-02-17 | — | — | US | disclosed |
| WO-2004056830-A1 | PYRROLOPYRIMIDINE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037999-A1 | Pyrrolopyrimidine derivatives | CCNA1, CCNT1, TP53 | PDGFRB 2465/4885EGFR 2758/4885ERBB2 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.